Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$46.31 - $62.7 $10.2 Million - $13.8 Million
-219,483 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$55.51 - $69.94 $25,368 - $31,962
457 Added 0.21%
219,483 $13.8 Million
Q3 2020

Nov 13, 2020

BUY
$42.19 - $69.61 $7.26 Million - $12 Million
172,174 Added 367.48%
219,026 $14.7 Million
Q2 2020

Aug 12, 2020

SELL
$27.55 - $43.28 $1.57 Million - $2.47 Million
-57,030 Reduced 54.9%
46,852 $1.96 Million
Q1 2020

May 13, 2020

SELL
$23.16 - $47.8 $389,667 - $804,235
-16,825 Reduced 13.94%
103,882 $3.27 Million
Q4 2019

Feb 13, 2020

SELL
$27.97 - $40.38 $237,437 - $342,785
-8,489 Reduced 6.57%
120,707 $4.87 Million
Q3 2019

Nov 13, 2019

BUY
$31.65 - $46.94 $1.17 Million - $1.73 Million
36,873 Added 39.94%
129,196 $4.2 Million
Q2 2019

Aug 09, 2019

BUY
$32.5 - $49.12 $3 Million - $4.53 Million
92,323 New
92,323 $4.47 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.